Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma Not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature
Mangogna, Alessandro, Cox, Maria Christina, Ruco, Luigi, Lopez, Gianluca, Belmonte, Beatrice, Di Napoli, AriannaVolume:
10
Journal:
Diagnostics
DOI:
10.3390/diagnostics10060341
Date:
May, 2020
File:
PDF, 2.00 MB
2020